Compare Adobe Systems Inc (ADBE) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adobe Systems Inc vs Illumina, Inc. — how do they compare? Adobe Systems Inc trades at $258.49 (market cap $104.82B), while Illumina, Inc. trades at $191.47 (market cap $29.12B). The key difference: Adobe Systems Inc is far larger — about 3.6× Illumina, Inc.'s market cap, and Illumina, Inc. is trading nearer its 52-week high, Adobe Systems Inc nearer its low. Which is the better fit depends on your goals.
| ADBE | ILMN | |
|---|---|---|
Market Cap | $104.82B | $29.12B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $367.46 | $205.10 |
52-Week Low | $193.41 | $91.00 |
Enterprise Value | $106.26B | $30.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $256.30, down 6.1% on the day amid broader tech sector weakness. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $5.96 versus $5.82 expected. Technical indicators show a bullish moving average trend but neutral oscillators, with key support at $252. Revenue grew to $23.77B in 2025 with impressive 28.69% net margins.
Adobe presents a compelling value opportunity trading below analyst consensus targets despite AI competition concerns. The company's robust cash flow generation and market leadership in creative software support long-term growth, though investor sentiment remains cautious due to CEO transition and AI disruption risks. Wall Street maintains a buy-heavy rating with $248.86 average price target.
Illumina (ILMN) trades at $191.32, down 0.25% on the day, with a bullish earnings trend after beating Q2 2026 estimates. The stock shows strong profitability with a net margin of 18.34% and positive cash flow, though technical indicators signal near-term bearish pressure. Recent news highlights institutional buying and AI partnerships boosting growth prospects.
Outlook remains positive with a consensus price target of $201.58, offering ~5% upside, supported by solid fundamentals and analyst optimism. Risks include high valuation multiples and competitive pressures in genomics. The stock presents a growth opportunity with manageable near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
